Anti-sickness tablets for Mounjaro: what works, what to ask, and when it passes

You've just had your first (or next) Mounjaro dose and you feel rough

That queasy stretch after a new dose or step-up is one of the most common things our prescribers hear about, especially in the early weeks of treatment. Tirzepatide works partly by slowing how quickly your stomach empties, and that effect is what causes nausea for many people. It is not a sign that the medicine is wrong for you. For most people it settles without any intervention at all, usually within days to a fortnight.

That said, if you are reading this at 7am on a Monday morning feeling genuinely unwell, knowing your options matters. The most widely available anti-sickness tablets in UK pharmacies fall into a few categories. Cyclizine (sold as Valoid and in other branded forms) is an antihistamine antiemetic available over the counter. Promethazine (Phenergan) is in the same family and widely stocked. Domperidone works differently, by speeding gastric motility, which is particularly relevant to GLP-1 related nausea — but it is now prescription-only in the UK at the standard anti-nausea dose, so you would need a clinician to prescribe it. Metoclopramide is similarly prescription-only. Prochlorperazine (Buccastem) is available in a low-dose buccal form over the counter for short-term nausea. If you are unsure which options are appropriate for your situation, our dedicated page on whether you can take anti-sickness tablets with Mounjaro walks through the key considerations in detail. You can read more about the full pattern of Mounjaro side effects to understand where nausea sits alongside the rest.

None of these should be taken without checking the leaflet and, ideally, running it past your prescriber first. Interactions, existing conditions, and how your body is responding to tirzepatide all shape the right choice. That is not a bureaucratic hurdle; it is just good medicine.

Why the timing and dose of your Mounjaro injection changes the nausea picture

Most of the clinical trial data on tirzepatide shows that nausea clusters around dose increases. In SURMOUNT-1, the large phase-3 trial published in the New England Journal of Medicine, gastrointestinal side effects were the most frequently reported events and were described as generally mild to moderate and transient. They tended to resolve as participants continued treatment at a stable dose.

That gives you a useful framework. The nausea you feel at 2.5mg is likely worse than what you will feel two months later at the same dose, your system adjusts. When you step up, a milder version of the same adjustment period often follows. Understanding what causes Mounjaro sickness in more detail can help you distinguish the expected pattern from something that needs attention.

Practical adjustments that many people find helpful alongside, or instead of, anti-sickness tablets: eating smaller portions, avoiding high-fat or very rich meals close to your injection day, keeping water nearby, injecting in the evening so the peak nausea window passes during sleep, and giving yourself a quieter day after stepping up if you can plan ahead. Some people prefer to book their dose increase for a week when they know they are at home rather than travelling, a holiday or work trip is rarely the right moment to try a higher dose for the first time.

If you are looking for more specific guidance on managing this at the symptom level, our overview of anti-sickness approaches for Mounjaro covers the non-medication strategies in more detail.

When to speak to a prescriber rather than reaching for the pharmacy shelf

Over-the-counter anti-sickness tablets for Mounjaro are a reasonable short-term support for mild nausea during the adjustment period. They are not a substitute for clinical review if nausea is severe, stops you eating or drinking, or is affecting your daily life week after week. The MHRA's January 2026 Drug Safety Update for GLP-1 medicines highlighted that severe, persistent stomach pain (particularly pain that radiates to the back, with or without vomiting) warrants urgent medical attention as it can indicate acute pancreatitis, a rare but serious complication. Do not manage that at home with anti-sickness tablets. Report suspected side effects, including anything unexpected, at the MHRA's Yellow Card scheme.

There is also the question of whether anti-sickness tablets are compatible with your other medicines. Domperidone and metoclopramide, for example, both have known interactions and contraindications. Antihistamine antiemetics can cause drowsiness. Your prescriber can take your full medical picture into account in a way a quick search cannot.

If you want to talk this through with a clinician who knows tirzepatide well, the team at our clinical team reviews these queries regularly. Details on how the consultation process works are on our Mounjaro treatment page. For context on what the private treatment involves, including what a month's supply typically costs, our guide to getting Mounjaro through a regulated online pharmacy covers the steps clearly. Anyone who is unsure whether tirzepatide is suitable for them in the first place can check our treatment overview for the eligibility outline.

If you would like personalised input on managing nausea during treatment, speak to our prescribers through a free consultation, they are available seven days a week for aftercare as well as new queries.